{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "A new study suggests the reason for  the association may be that antibiotics destroy not only disease-causing microbes, but also those that are helpful to the developing immune system.", "headline": {"main": "Antibiotic Use in First Year May Increase Asthma Risk", "print_headline": "Antibiotic Use in First Year May Increase Asthma Risk"}, "abstract": null, "print_page": "7", "word_count": "660", "_id": "548b7f1a79881004157bb907", "snippet": "A new study suggests the reason for  the association may be that antibiotics destroy not only disease-causing microbes, but also those that are helpful to the developing immune system.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/06/19/health/19asth.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Antibiotics", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Asthma", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Bacteria", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Children and Youth", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2007-06-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Genetic tests may soon help doctors find the best treatment for each individual. ", "headline": {"main": "On the Horizon, Personalized Depression Drugs", "kicker": "Behavior", "print_headline": "On the Horizon, Personalized Depression Drugs", "content_kicker": "Behavior"}, "abstract": null, "print_page": "6", "word_count": "865", "_id": "548b7deb79881004157bb8e8", "snippet": "Genetic tests may soon help doctors find the best treatment for each individual.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/06/19/health/psychology/19beha.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2007/06/19/health/19beha.751.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/06/19/health/19beha.751.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Psychology", "keywords": [{"value": "Antidepressants", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Depression (Mental)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Psychiatry and Psychiatrists", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Richard", "middlename": "A.", "lastname": "FRIEDMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RICHARD A. FRIEDMAN, M.D"}, "document_type": "article", "pub_date": "2007-06-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Regular aspirin use may significantly reduce the incidence of both cancer and heart disease, according to a large new study. ", "headline": {"main": "Patterns: Aspirin Linked to Lower Risk of Cancer and Heart Disease", "print_headline": "Aspirin Linked to Lower Risk Of Cancer and Heart Disease", "content_kicker": "Vital Signs"}, "abstract": null, "print_page": "6", "word_count": "289", "_id": "548b7da579881004157bb8e0", "snippet": "Regular aspirin use may significantly reduce the incidence of both cancer and heart disease, according to a large new study.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/06/19/health/19patt.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2007/06/19/health/19vitals.753.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/06/19/health/19vitals.753.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Aspirin", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Women", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2007-06-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Imagine that you are depressed and see a psychiatrist who explains that you have clinical depression and would benefit from an antidepressant. So far, so good. But then the doctor tells you there is a 60 percent chance that you'll feel better with this antidepressant and that it could take as long as four to six weeks to find out, during which time you'll probably have some side effects from the drug. I have just described the state-of-the-art pharmacologic treatment of major depression in 2007. Don't get me wrong; we have very effective and safe treatments for a broad array of psychiatric disorders. But in everyday clinical practice, we have little ability to predict which specific treatment will work best for you.", "headline": {"main": "On the Horizon, Personalized Depression Drugs", "kicker": "BEHAVIOR"}, "abstract": null, "print_page": "6", "word_count": 881, "_id": "4fd27c4a8eb7c8105d84275b", "snippet": "Imagine that you are depressed and see a psychiatrist who explains that you have clinical depression and would benefit from an antidepressant. So far, so good. But then the doctor tells you there is a 60 percent chance that you'll feel better with...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A00E0DA1731F93AA25755C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"qualifier": "M.D", "firstname": "Richard", "middlename": "A.", "lastname": "FRIEDMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RICHARD A. FRIEDMAN, M.D"}, "document_type": "article", "pub_date": "2007-06-19T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Regular aspirin use may significantly reduce the incidence of both cancer and heart disease, according to a large new study, but other nonsteroidal anti-inflammatory drugs, or Nsaids, have no effect. Researchers studied 22,507 postmenopausal women, following them for 10 years. All reported their aspirin and Nsaid use as part of a detailed physical and behavioral health questionnaire. None of the women had cancer or heart disease at the start of the study.", "headline": {"main": "Aspirin Linked to Lower Risk Of Cancer and Heart Disease", "kicker": "VITAL SIGNS"}, "abstract": "Dr Aditya Bardia, Mayo clinic internal medicine resident, leads study that finds regular aspirin use may reduce risk of getting cancer and heart disease; research, which is published in Journal of the National Cancer Institute, says that other non-steroidal anti-inflammatory drugs had no effect on prevention; drawing (M)", "print_page": "6", "word_count": 291, "_id": "4fd28fe38eb7c8105d86755c", "snippet": "Regular aspirin use may significantly reduce the incidence of both cancer and heart disease, according to a large new study, but other nonsteroidal anti-inflammatory drugs, or Nsaids, have no effect.     Researchers studied 22,507 postmenopausal...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9804E5DE133FF93AA25755C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BARDIA, ADITYA"}, {"name": "organizations", "value": "JOURNAL OF THE NATIONAL CANCER INSTITUTE"}, {"name": "organizations", "value": "MAYO CLINIC"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "ASPIRIN"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2007-06-19T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "If marijuana has therapeutic potential, it should be required to pass muster with the F.D.A. like any other medicine.", "headline": {"main": "Crackpot Legislation", "kicker": "Op-Ed Contributor", "print_headline": "Crackpot Legislation", "content_kicker": "Op-Ed Contributor"}, "abstract": null, "print_page": "9", "word_count": "891", "_id": "548b6a9379881004157bb6ef", "snippet": "If marijuana has therapeutic potential, it should be required to pass muster with the F.D.A. like any other medicine.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/06/17/opinion/nyregionopinions/17CImiller.html", "multimedia": [], "subsection_name": "nyregionopinions", "keywords": [{"value": "Marijuana", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Drug Enforcement Administration", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": {"person": [{"firstname": "Henry", "middlename": "I.", "lastname": "MILLER", "rank": 1, "role": "reported", "organization": ""}], "original": "By HENRY I. MILLER"}, "document_type": "article", "pub_date": "2007-06-17T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "Those treating pain make subjective choices about dosage. When a doctor gets it wrong, is it a mistake or a felony?", "headline": {"seo": "Pain - Doctors - Medicine and Health - Prescription Drugs - Healthcare - Insurance", "main": "When Is a Pain Doctor a Drug Pusher?", "kicker": "From the Magazine", "print_headline": "Doctor or Drug Pusher", "content_kicker": "Cover Story"}, "abstract": null, "print_page": null, "word_count": "8314", "_id": "5478234779881006dca8baed", "snippet": "Those treating pain make subjective choices about dosage. When a doctor gets it wrong, is it a mistake or a felony?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/06/17/magazine/17pain-t.html", "multimedia": [{"width": 600, "url": "images/2007/06/12/magazine/17pain600.1.jpg", "height": 300, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2007/06/12/magazine/17pain600.1.jpg", "xlargeheight": "300"}, "type": "image"}, {"width": 75, "url": "images/2007/06/12/magazine/17pain1a.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/06/12/magazine/17pain1a.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Pain", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Pain-Relieving Drugs", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drug Abuse and Traffic", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Malpractice", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Doctors", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Suits and Litigation", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "OxyContin (Drug)", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Tina", "rank": 1, "lastname": "ROSENBERG"}], "original": "By TINA ROSENBERG"}, "document_type": "article", "pub_date": "2007-06-17T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "The City Weekly Desk", "lead_paragraph": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow suit and New Jersey has two bills with bipartisan support. Indeed, a number of states have had similar measures in play over the last year, in addition to the 12 that have already passed such laws. The picture is very different at the federal level, where marijuana is branded as an illegal drug. An amendment to a recent drug safety bill would require all purveyors of state-authorized medical marijuana to be subject to Food and Drug Administration regulation. The senator who introduced this amendment said that making any drug available without F.D.A. review or proof of safety and effectiveness would set a dangerous precedent that would threaten patient safety. Marijuana advocates have opposed the bill, because it would close medical marijuana cooperatives and create barriers to the use of the drug.", "headline": {"main": "Crackpot Legislation"}, "abstract": "Op-Ed article by Dr Henry Miller, Hoover Institution fellow, on rancorous debate over medical marijuana; holds drugs like Sativex, spray that delivers precise dose of drug without causing 'high' that many patients view as undesirable side effect, would both benefit patients and satisfy legal requirement that marketed medicines must be proven safe and effective (M)", "print_page": "9", "word_count": 923, "_id": "4fd275238eb7c8105d834934", "snippet": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A00E3DA153FF934A25755C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SATIVEX (DRUG)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MARIJUANA"}], "byline": {"person": [{"firstname": "Henry", "middlename": "I.", "lastname": "Miller", "rank": 1, "role": "reported", "organization": ""}], "original": "By Henry I. Miller"}, "document_type": "article", "pub_date": "2007-06-17T00:00:00Z", "section_name": "Health; New York and Region; Opinion"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Westchester Weekly Desk", "lead_paragraph": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow suit and New Jersey has two bills with bipartisan support. Indeed, a number of states have had similar measures in play over the last year, in addition to the 12 that have already passed such laws. The picture is very different at the federal level, where marijuana is branded as an illegal drug. An amendment to a recent drug safety bill would require all purveyors of state-authorized medical marijuana to be subject to Food and Drug Administration regulation. The senator who introduced this amendment said that making any drug available without F.D.A. review or proof of safety and effectiveness would set a dangerous precedent that would threaten patient safety. Marijuana advocates have opposed the bill, because it would close medical marijuana cooperatives and create barriers to the use of the drug.", "headline": {"main": "Crackpot Legislation"}, "abstract": "Op-Ed article by Dr Henry Miller, Hoover Institution fellow, on rancorous debate over medical marijuana; holds drugs like Sativex, spray that delivers precise dose of drug without causing 'high' that many patients view as undesirable side effect, would both benefit patients and satisfy legal requirement that marketed medicines must be proven safe and effective (M)", "print_page": "15", "word_count": 923, "_id": "4fd28fe38eb7c8105d8674e9", "snippet": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A0DE5D6143FF934A25755C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SATIVEX (DRUG)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MARIJUANA"}], "byline": {"person": [{"firstname": "Henry", "middlename": "I.", "lastname": "Miller", "rank": 1, "role": "reported", "organization": ""}], "original": "By Henry I. Miller"}, "document_type": "article", "pub_date": "2007-06-17T00:00:00Z", "section_name": "Health; New York and Region; Opinion"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "New Jersey Weekly Desk", "lead_paragraph": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow suit and New Jersey has two bills with bipartisan support. Indeed, a number of states have had similar measures in play over the last year, in addition to the 12 that have already passed such laws. The picture is very different at the federal level, where marijuana is branded as an illegal drug. An amendment to a recent drug safety bill would require all purveyors of state-authorized medical marijuana to be subject to Food and Drug Administration regulation. The senator who introduced this amendment said that making any drug available without F.D.A. review or proof of safety and effectiveness would set a dangerous precedent that would threaten patient safety. Marijuana advocates have opposed the bill, because it would close medical marijuana cooperatives and create barriers to the use of the drug.", "headline": {"main": "Crackpot Legislation"}, "abstract": "Op-Ed article by Dr Henry Miller, Hoover Institution fellow, on rancorous debate over medical marijuana; holds drugs like Sativex, spray that delivers precise dose of drug without causing 'high' that many patients view as undesirable side effect, would both benefit patients and satisfy legal requirement that marketed medicines must be proven safe and effective (M)", "print_page": "15", "word_count": 923, "_id": "4fd27c4a8eb7c8105d842702", "snippet": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A0DE2DF153FF934A25755C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SATIVEX (DRUG)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MARIJUANA"}], "byline": {"person": [{"firstname": "Henry", "middlename": "I.", "lastname": "Miller", "rank": 1, "role": "reported", "organization": ""}], "original": "By Henry I. Miller"}, "document_type": "article", "pub_date": "2007-06-17T00:00:00Z", "section_name": "Health; New York and Region; Opinion"}], "meta": {"hits": 11, "offset": 0, "time": 77}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}